D. E. Shaw & Co., Inc. - CONATUS PHARMACEUTICALS INC ownership

CONATUS PHARMACEUTICALS INC's ticker is CNAT and the CUSIP is 20600T108. A total of 40 filers reported holding CONATUS PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 0.25 and the average weighting 0.0%.

Quarter-by-quarter ownership
D. E. Shaw & Co., Inc. ownership history of CONATUS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2019$13,000
-86.3%
51,441
-41.3%
0.00%
Q1 2019$95,000
-12.0%
87,667
+41.0%
0.00%
Q4 2018$108,000
-55.0%
62,163
+50.4%
0.00%
Q3 2018$240,000
-15.8%
41,337
-37.8%
0.00%
Q2 2018$285,000
+56.6%
66,506
+114.7%
0.00%
Q1 2018$182,000
-13.3%
30,981
-31.7%
0.00%
Q4 2017$210,000
+238.7%
45,382
+302.7%
0.00%
Q3 2017$62,000
-64.6%
11,269
-87.2%
0.00%
Q3 2016$175,000
+88.2%
87,788
+94.5%
0.00%
Q2 2016$93,000
+173.5%
45,139
+183.3%
0.00%
Q1 2016$34,000
-81.2%
15,932
-74.6%
0.00%
Q4 2015$181,000
+101.1%
62,720
+259.8%
0.00%
Q2 2015$90,00017,4300.00%
Other shareholders
CONATUS PHARMACEUTICALS INC shareholders Q2 2019
NameSharesValueWeighting ↓
JBF Capital, Inc. 520,553$161,0000.03%
Kalos Management, Inc. 43,940$13,0000.01%
ACADIAN ASSET MANAGEMENT LLC 1,351,000$419,0000.00%
Quilter Plc 60,546$19,0000.00%
ALBION FINANCIAL GROUP /UT 12,000$4,0000.00%
REILLY FINANCIAL ADVISORS, LLC 22,011$7,0000.00%
MORGAN STANLEY 1,900$1,0000.00%
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 24,900$8,0000.00%
BlackRock Inc. 645,611$200,0000.00%
Bank of New York Mellon Corp 137,500$43,0000.00%
View complete list of CONATUS PHARMACEUTICALS INC shareholders